|
Sanofi-aventis Sends Letter to Genzyme Seeking Clarification on Potential Board Actions
|
08 November 2010 |
|
Sanofi Pasteur's Dengue Vaccine in Final Stage of Clinical Development
|
04 November 2010 |
|
Sanofi-aventis to Acquire BMP Sunstone creating a Strong Consumer Healthcare Platform in China
|
29 October 2010 |
|
Sanofi-aventis Establishes Research Collaboration with Harvard University
|
21 October 2010 |
|
Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme
|
05 October 2010 |
|
Jevtana® Improves Survival in Advanced Prostate Cancer Patients
|
04 October 2010 |
|
Sanofi Pasteur to Acquire VaxDesign, a U.S. biotechnology company
|
29 September 2010 |
|
Adding Lantus® to Oral Antidiabetic Drug Therapy Further Reduced Blood Sugar in Patients with Type 2 Diabetes
|
21 September 2010 |
|
Sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
|
30 August 2010 |
|
Sanofi-aventis expresses concern over the approval of another version of enoxaparin sodium
|
27 July 2010 |